facebook twitter linkedin
  • images/stories/slider.png
  • images/stories/slider2.png
  • images/stories/slider3.png
  • images/stories/slider4.png

NEWS RELEASES

  • Selvita to release the most recent results from its oncology programs at the AACR Annual Meeting 2015

    April 17, 2015, Krakow, Poland - Selvita (WSE:SLV), the largest drug discovery company in Central and Eastern Europe, will publish the most recent data from its oncology programs at the upcoming AACR Annual Meeting 2015, which will take place on 18 –…

    Read More...

  • Selvita initiates IND-enabling Studies for its first-in-class PIM/FLT3 inhibitor

    Krakow, 31 March 2015 - Selvita (WSE:SLV), the largest drug discovery company in Central and Eastern Europe, announced today that it is commencing IND-enabling studies for SEL24 project, the company’s first oncology drug candidate. &n SEL24 is a nov…

    Read More...

  • Selvita expands its proteomics services offer

    Krakow, 16 March 2015 - Selvita, global integrated drug discovery partner for the pharmaceutical and biotechnology industries with offices in Greater Boston Area and Krakow, Poland, announced today that it has expanded its portfolio of protein chemis…

    Read More...